Arvinas (ARVN) Revenue (2017 - 2026)
Arvinas (ARVN) recorded quarterly Revenue of $15.6 million in Q1 2026, up 64.21% quarter-over-quarter from $9.5 million in Q4 2025, and down 91.74% on a YoY basis from $188.8 million in Q1 2025.
Arvinas (ARVN) Revenue (2017 - 2026) Analysis & Trends
Arvinas' Revenue history runs 10 years deep, the most recent figure standing at $15.6 million for Q1 2026.
- In Q1 2026, Revenue fell 91.74% year-over-year to $15.6 million; the TTM figure through Mar 2026 stood at $89.4 million (down 79.06% YoY), while the FY2025 annual figure was $262.6 million, changed 0.3% from the prior year.
- Revenue was $15.6 million for Q1 2026 at Arvinas, up from $9.5 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $188.8 million in Q1 2025 to a low of -$43.1 million in Q4 2023.
- Historically, Revenue has averaged $44.2 million across 5 years, with a median of $33.8 million in 2022.
- The sharpest annual moves came in 2023 and 2025: Revenue slumped 214.02% in 2023, then soared 646.25% in 2025.
- A 5-year view of Revenue shows it stood at $37.8 million in 2022, then plunged by 214.02% to -$43.1 million in 2023, then surged by 237.35% to $59.2 million in 2024, then slumped by 83.95% to $9.5 million in 2025, then jumped by 64.21% to $15.6 million in 2026.
- The last three Revenue figures came in at $15.6 million (Q1 2026), $9.5 million (Q4 2025), and $41.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 5.21 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 306.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 2.99 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arvinas | 492.16 Mn | -122.74 Mn | - | 15.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.60 Mn |
| Dec 31, 2025 | 9.50 Mn |
| Sep 30, 2025 | 41.90 Mn |
| Jun 30, 2025 | 22.40 Mn |
| Mar 31, 2025 | 188.80 Mn |
| Dec 31, 2024 | 59.20 Mn |
| Sep 30, 2024 | 102.40 Mn |
| Jun 30, 2024 | 76.50 Mn |
| Mar 31, 2024 | 25.30 Mn |
| Dec 31, 2023 | -43.10 Mn |
| Sep 30, 2023 | 34.60 Mn |
| Jun 30, 2023 | 54.50 Mn |
| Mar 31, 2023 | 32.50 Mn |
| Dec 31, 2022 | 37.80 Mn |
| Sep 30, 2022 | 33.20 Mn |
| Jun 30, 2022 | 33.80 Mn |
| Mar 31, 2022 | 26.50 Mn |
| Dec 31, 2021 | 33.20 Mn |
| Sep 30, 2021 | 9.30 Mn |
| Jun 30, 2021 | 5.50 Mn |